• 1
    Li CY, Lam LT & Lam KW. Acid phosphatase isoenzyme in human leukocytes in normal and pathological conditions. J Histochem Cytochem 1970; 18:47381.
  • 2
    Lord DK, Cross NCP & Bevilacqua MA et al. Type 5 acid phosphatase. Sequence expression and chromosomal localization of a differentiation-associated protein of the human macrophage. Eur J Biochem 1990; 189:28793.
  • 3
    Li CY, Yam LT & Lam KW. Studies of acid phosphatase isoenzymes in human leukocytes. Demonstration of isoenzyme cell specificity. J Histochem Cytochem 1970; 18:90110.
  • 4
    Que L & Scarrow RC. Active sites of binuclear iron-oxo proteins. Am Chem Soc Symposium 1988; 372:15278.
  • 5
    Hayman AR & Cox TM. Purple acid phosphatase of the human macrophage and osteoclast. Characterization, molecular properties and crystallization of the recombinant di-iron-oxo protein secreted by baculovirus-infected insect cells. J Biol Chem 1994; 262:5962.
  • 6
    Sibille J-C, Doi K & Aisen P. Hydroxyl radical formation and iron-binding proteins. Stimulation by the purple acid phosphatases. J Biol Chem 1987; 262:5962.
  • 7
    Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, Evans MJ & Cox TM. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteoporosis. Development 1996; 122:315162.
  • 8
    Ketcham CM, Baumbach GA, Bazer FW & Roberts RM. The type 5 acid phosphatase from spleen of humans with hairy cell leukaemia. Purification properties, immunological characterization and comparison with porcine uteroferrin. J Biol Chem 1985; 260:576876.
  • 9
    Robinson DB & Glew RH. Acid phosphatase in Gaucher's disease. Clin Chem 1980; 26:371.
  • 10
    Boltz-Nitulescu G, Wiltschke C, Holzinger C, Fellinger A, Scheiner O, Gessl A & Forster O. Differentiation of rat bone marrow cells into macrophages under the influence of mouse L929 cell supernatant. J Leukoc Biol 1987; 41:8391.
  • 11
    Gomori G. Histochemical methods for acid phosphatase. J Histochem Cytochem 1956; 4:45361.
  • 12
    Johnston RB Jr. Measurement of inline imagesecreted by monocytes and macrophages. Methods Enzymol 1982; 105:3659.
  • 13
    Ding A, Nathan CF & Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates for mouse peritoneal macrophages. J Immunol 1988; 141:240712.
  • 14
    Hayman AR, Warburton MJ, Pringle JAS, Coles B & Chambers TJ. Purification and characterization of a tartrate-resistant acid phosphatase from human osteoclastomas. Biochem J 1989; 261:6019.
  • 15
    Echetebu ZO, Cox TM & Moss DW. Antibodies to porcine uteroferrin used in the measurement of human tartrate-resistant acid phosphatase. Clin Chem 1987; 33:18326.
  • 16
    Pollock JD, Williams DA & Gifford MA et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995; 9:2029.
  • 17
    Robinson JP. Handbook of Flow Cytometry Methods. New York: A. A. Wiley-Liss, 1993.
  • 18
    Nilsson I-M, Lee JC, Bremell Ryden C & Tarkowski A. The role of staphylococcal polysaccharide microcapsule expression in septicaemia and septic arthritis. Infect Immun 1997; 65:421621.
  • 19
    Snedecor GW & Cochran WG. Statistical Methods, 7th edn. Ames: Iowa State University Press, 1980::140;1436;255–333.
  • 20
    Gordon S, Lawson L, Rabinowitz S, Croker PR, Morris L & Perry VH. Antigen markers of macrophage differentiation in murine tissues. In: RussellS, GordonS, eds. Macrophage Biology and Activation. Current Topics in Microbiology and Immunology, Vol. 181. Berlin: Springer-Verlag, 1992::137.
  • 21
    Hirsch S & Gordon S. Polymorphic expression of a neutrophil differentiation antigen revealed by a monoclonal antibody F7/4. Immunogenetics 1983; 18:22939.
  • 22
    Lagasse E & Weissman IL. Flow cytometric identification of murine neutrophils and monocytes. J Immunol Methods 1996; 197:13950.DOI: 10.1016/0022-1759(96)00138-x
  • 23
    Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 1998; 70:83243.
  • 24
    Hseih C-S, Macatonia SE, Tripp CS, Wolff SF, Garra AO & Murphy KM. Development of Th1 CD 4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260:54749.
  • 25
    Altare F, Durandy A & Lammas D et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280:143235.DOI: 10.1126/science.280.5368.1432
  • 26
    Zhang T, Kawakami K, Quereshi MH, Okamura H, Kuinoto N & Sato A. Interleukin-12 and IL-18 synergistically induce the fungicidal activity of murine exudate cells against Cryptococcus neoforms through production of gamma interferon by natural killer cells. Infect Immun 1997; 65:35949.
  • 27
    Diefenbach A, Schindler H, Röllinghoff M, Yokoyama WM & Bogdanm C. Requirement for type 2 NO synthase for IL-12 signalling in innate immunity. Science 1999; 284:9515.DOI: 10.1126/science.284.5416.951
  • 28
    Saftig P, Hartmann D & Lullmann-Rauch R et al. Mice deficient in lysosomal acid phosphatase develop lysosomal storage in the kidney and central nervous system. J Biol Chem 1997; 272:1862835.
  • 29
    Musson RA, Shafran H & Henson PM. Intracellular levels and stimulated release of lysosomal enzymes from human peripheral blood monocytes and monocyte-derived macrophages. J Reticuloendothelial Soc 1980; 28:24964.
  • 30
    Wenzel SE, Trudeau JB, Riches DW, Westcott JY & Henson PM. Peritoneal lavage fluid alters patterns of eicosanoid production in murine bone marrow derived and peritoneal macrophages: dependency on the inflammatory state of the peritoneum. Inflammation 1993; 17:74356.
  • 31
    Severn A, Xu D, Doyle J, Leal LM, O'donnell CA, Brett SJ, Moss DW & Liew FY. Pre-exposure of murine macrophages to lipopolysaccharide inhibits induction of nitric oxide synthase and reduces leishmanicidal activity. Eur J Immunol 1993; 23:17114.
  • 32
    Johnston RB & Kitagawa S. Molecular basis for the enhanced respiratory burst of activated macrophages. Federation Proc 1985; 44:292731.
  • 33
    Phillips WA & Hamilton JA. Phorbol ester-stimulated superoxide production by murine bone marrow derived macrophages requires pre-exposure to cytokines. J Immunol 1989; 142:24459.
  • 34
    Bradbury MG & Moreno C. Effect of lipoarabinomannan and mycobacteria on tumour necrosis factor production by different populations of murine macrophages. Clin Exp Immunol 1993; 94:5763.
  • 35
    Le Blanc PA, Katz MR & Russell SW. A discrete population of mononuclear phagocytes depleted by monoclonal antibody. Infect Immun 1980; 29:5205.
  • 36
    Kanagasundaram V, Christy E, Hamilton JA & Jawarowski A. Different pathways of colony-stimulating factor 1 degradation in macrophage populations revealed by Wortmannin sensitivity. Biochem J 1998; 330:197202.
  • 37
    Harbrecht BG, Di Silvo M, Demetris AJ, Simmons RL & Billar TR. Tumour necrosis factor-alpha regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia. Hepatology 1994; 20:105560.
  • 38
    Okusawa S, Gelfsand SA, Kejama T, Connolly RJ & Dinarello CA. Interleukin-1 induces a shock like state in rabbits. J Clin Invest 1988; 81:116272.
  • 39
    Hayman AR, Bune AJ, Bradley JR, Rashbass J & Cox TM. Osteoclastic tartrate-resistant acid phosphatase (Acp 5). Its localization to dendritic cells and diverse murine tissues. J Histochem Cytochem 2000; 48:21927.
  • 40
    Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9:27196.
  • 41
    Halleen JM, Raisenen S & Salo JJ et al. Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem 1999; 274:2290710.
  • 42
    Hattor Y, Kasai K, Akimoto K & Thiemermann C. Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CD14 dependent pathway. Biochim Biophys Res Commun 1997; 233:3759.DOI: 10.1006/bbrc.1997.6462
  • 43
    Busam K, Gieringer C, Freudenberg M & Hohmann H-P. Staphylococcus aureus and derived exotoxins induce nuclear factor κB-like activity in murine bone marrow macrophages. Infect Immun 1992; 60:200815.
  • 44
    Wardle EN. Bacteraemic and endotoxic shock. Br J Hosp Med 1979; 21:22331.
  • 45
    Maurin M & Raoult D. Phagolysosomal alkalinisation and intracellular killing of Staphylococcus aureus by Amikacin. J Infect Dis 1994; 169:3306.
  • 46
    Gallin J. Recent advances in chronic gramulomatous diseases. Ann Intern Med 1983; 99:65774.
  • 47
    Drexler HG & Gigac SM. Characterization and expression of tartrate-resistant acid phosphatase (TRAP) in haematopoietic cells. Leukaemia 1994; 8:35468.
  • 48
    Janckila AJ, Yaziji H, Lear SC, Martin AW & Yam LT. Localization of tartrate-resistant acid phosphatase in human placenta. Histochem J 1994; 28:195200.
  • 49
    Ek-Rylander B, Flores M, Wendel M, Heinegård D & Andersson G. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem 1994; 269:148536.
  • 50
    Ashkar S, Weber GF & Panoutsakopoulou V et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000; 287:85964.
  • 51
    Kubota T, Zhang Q, Wrana JL, Ber R, Aubin JE, Butler WT & Sodek J. Multiple forms of Spp 1 (secreted phosphoprotein, osteopontin) synthesized by normal and transformed rat bone cell populations: regulation by TGF-beta. Biochem Biophys Res Commun 1989; 162:145357.